CAN1012 Combined With PD-1 in Patients With Solid Tumors

Clinical trial NCT06410703 · UNKNOWN

Trial details

NCT number: NCT06410703
Sponsor: Canwell Biotech Limited
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-06-27
Primary completion: 2025-05-30
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.